Haleon (HLN) Share-based Compensation (2023 - 2025)

Haleon's (HLN) quarterly Share-based Compensation came in at $56.3 million in Q4 2025, up 25.94% on a QoQ basis from $44.7 million in Q4 2023.

Haleon (HLN) Share-based Compensation (2023 - 2025) Analysis & Trends

Haleon (HLN) has 2 years of Share-based Compensation data on file, last reported at $56.3 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Stock Comp. (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-	-
2	Teva Pharmaceutical Industries	43.42 Bn	39.76 Bn	2.15 Bn	40.00 Mn
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn	26.00 Mn
4	Takeda Pharmaceutical	28.77 Bn	22.98 Bn	5.10 Bn	114.12 Mn
5	United Therapeutics	22.29 Bn	19.63 Bn	683.80 Mn	19.00 Mn
6	Viatris	18.78 Bn	17.89 Bn	1.46 Bn	30.40 Mn
7	Neurocrine Biosciences	15.66 Bn	15.27 Bn	935.80 Mn	65.00 Mn
8	Elanco Animal Health	11.91 Bn	11.38 Bn	798.00 Mn	7.00 Mn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-	-
10	Alkermes	8.20 Bn	7.55 Bn	397.90 Mn	31.14 Mn

Download Data